These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6914902)

  • 21. Interaction between factor XII (Hageman factor), high molecular weight kininogen and prekallikrein.
    Chan JY; Habal FM; Burrowes CE; Movat HZ
    Thromb Res; 1976 Nov; 9(5):423-33. PubMed ID: 996830
    [No Abstract]   [Full Text] [Related]  

  • 22. The autoactivation of rabbit Hageman factor.
    Wiggins RC; Cochrane CC
    J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation.
    Gailani D; Broze GJ
    Blood; 1993 Aug; 82(3):813-9. PubMed ID: 8338946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of surface-mediated activation of bovine factor XII and plasma prekallikrein.
    Sugo T; Hamaguchi A; Shimada T; Kato H; Iwanaga S
    J Biochem; 1982 Sep; 92(3):689-98. PubMed ID: 6923896
    [No Abstract]   [Full Text] [Related]  

  • 25. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.
    Wiggins RC
    J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional characterization of an abnormal factor XII molecule (F XII Bern).
    Wuillemin WA; Huber I; Furlan M; Lämmle B
    Blood; 1991 Aug; 78(4):997-1004. PubMed ID: 1868256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of bovine factor XII (Hageman factor) by plasma kallikrein.
    Fujikawa K; Heimark RL; Kurachi K; Davie EW
    Biochemistry; 1980 Apr; 19(7):1322-30. PubMed ID: 6155941
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
    Kaplan AP; Gruber B; Harpel PC
    Blood; 1985 Sep; 66(3):636-41. PubMed ID: 3875374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor).
    Tans G; Rosing J; Griffin JH
    J Biol Chem; 1983 Jul; 258(13):8215-22. PubMed ID: 6553053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein.
    Shimada T; Kato H; Iwanaga S
    J Biochem; 1987 Oct; 102(4):913-21. PubMed ID: 3436959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
    Steen Burrell KA; Layzer J; Sullenger BA
    J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Contact activation of prekallikrein and plasminogen in plasma].
    Veremeenko KN; Volokhonskaia LI; Kizim AI; Pogorelaia NF
    Ukr Biokhim Zh (1978); 1983; 55(3):295-301. PubMed ID: 6553425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.